LYV
LIVE

Serial Number

98275822

Owner

Health Management Holdings LLC

Attorney

Brittany L. Kulwicki

First Use Date

Jan 1, 2021

Filing Date

Nov 17, 2023

Add to watchlist:

No watchlists yet
View on USPTO

LYV Trademark

Serial Number: 98275822

LYV is a trademark filed by Health Management Holdings LLC on November 17, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Health Management Holdings LLC (4 trademarks)

18605 Detroit Avenue
Lakewood, OH 44107

Entity Type: 16

Trademark Details

Filing Date

November 17, 2023

Registration Date

Not Registered

First Use Anywhere

January 1, 2021

First Use in Commerce

January 1, 2021

Published for Opposition

March 4, 2025

Goods & Services

Consulting services in the field of hormone replacement therapy; Cosmetic body care services provided by health spas; Cosmetic skin care services, namely, facials; Cryotherapy services; Health care services, namely, stem cell therapy, infrared light-emitting diode (LED) therapy, platelet rich plasma (PRP) injections, hyperbaric oxygen therapy (HBOT), ozone therapy, minimally invasive threading therapy, facial and body composition scanning, medical testing of blood panels, micronutrients, food sensitivity, gut biome, heavy metal, genetic, and genotyping; Health spa services, namely, cosmetic body care services; Infrared sauna services; Intravenous (IV) hydration therapy services; Intravenous (IV) vitamin therapy services; Medical spa services, namely, minimally and non-invasive cosmetic and body fitness therapies; Metabolic testing for nutraceutical needs; Providing information about dietary supplements and nutrition; Providing medical aesthetic procedures, namely, treating the skin with dermal fillers and botulinum toxin; Providing weight loss programs and cosmetic body care services in the nature of non-surgical body contouring; Skin treatment, namely, the injection of dermal fillers to reduce the appearance of facial fine lines; Vitamin therapy

Botulinum toxin for medical use for use in the treatment of hyperhidrosis, excessive eye blinking, migraines, spastic disorders, cervical dystonia, detrusor hyperactivity, neuropathy pain, and wrinkles; Homeopathic supplements; Intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; Non-medicated, therapeutic skin creams for the treatment of inflammation and joint pain; Nutritional supplements; Probiotic supplements; Stem cells for medical purposes; Synthetic peptides for the treatment of inflammation, high blood pressure, immune system, blood clots, weight control, muscle growth, healing, hair loss, aging, sleep support, swelling, decreased energy, and mood support; Therapeutic agents for weight control and appetite suppression; Therapeutic pharmaceutical for the treatment of appetite, namely, appetite suppression and weight, namely, weight control; Vitamin supplements

On-line retail store services featuring a wide variety of consumer goods of others; On-line retail store services featuring a wide variety of health and wellness goods; Retail store services featuring a wide variety of consumer goods of others

Filing History

SOU EXTENSION RECEIVED WITH TEAS PETITION
Apr 30, 2026 TPEX
NOTICE OF REVIVAL - E-MAILED
Apr 30, 2026 NREV
PETITION TO REVIVE-GRANTED
Apr 30, 2026 PETG
TEAS PETITION TO REVIVE RECEIVED
Apr 30, 2026 PROA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 11, 2025 EXRA
SOU EXTENSION 1 GRANTED
Oct 10, 2025 EX1G
SOU EXTENSION 1 FILED
Oct 10, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Oct 10, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 29, 2025 NOAM
PUBLISHED FOR OPPOSITION
Mar 4, 2025 PUBO
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 4, 2025 NPUB
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 26, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 9, 2025 CNSA
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Feb 6, 2025 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jun 24, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Jun 24, 2024 GNSL
SUSPENSION LETTER WRITTEN
Jun 24, 2024 CNSL
ASSIGNED TO EXAMINER
Jun 23, 2024 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Feb 8, 2024 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 8, 2024 NWOS
NEW APPLICATION ENTERED
Nov 17, 2023 NWAP